Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1058 to 1107 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1058\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
scy1-like 1; telomerase regulation-associated protein; ht019 protein; telomerase regulation-associated protein; n-terminal kinase-like protein; teratoma-associated tyrosine kinase; n-terminal kinase-like. [source:refseq;acc:nm\_020680]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5412.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5913.4\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0926\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1059\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tubulin-specific chaperone c (tubulin-folding cofactor c) (cfc). [source:swissprot;acc:q15814]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5719.01\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6248.6\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1060\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative acyl-coa thioester hydrolase cgi-16 (ec 3.1.2.-). [source:swissprot;acc:q9y305]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1061\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear pore complex protein nup98 (nucleoporin nup98) (98 kda nucleoporin). [source:swissprot;acc:p52948]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5412.23\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5913.4\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1062\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ammecr1 protein. [source:refseq;acc:nm\_015365]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1063\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mrna-associated protein mrnp 41 (rae1 protein homolog). [source:swissprot;acc:p78406]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1064\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead-box protein. [source:refseq;acc:nm\_018665]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5719.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6248.6\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1065\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-(apurinic or apyrimidinic site) lyase (ec 4.2.99.18) (ap endonuclease 1) (apex nuclease) (apen) (ref-1 protein). [source:swissprot;acc:p27695]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6393.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6984.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09245\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1066\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
leucyl-trna synthetase. [source:refseq;acc:nm\_020117]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5417.06\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5917.79\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09244\vspace{3pt}}\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1067\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable leucyl-trna synthetase, mitochondrial precursor (ec 6.1.1.4) (leucine--trna ligase) (leurs). [source:swissprot;acc:q15031]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5417.07\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1.09243\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1068\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exocyst complex component sec15a. [source:swissprot;acc:q8tag9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6201.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6774.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09237\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1069\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
elongation factor 2 (ef-2). [source:swissprot;acc:p13639]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5494.73\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6001.08\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09215\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1070\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
metabotropic glutamate receptor 2 precursor (mglur2). [source:swissprot;acc:q14416]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1071\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
metabotropic glutamate receptor 3 precursor (mglur3). [source:swissprot;acc:q14832]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1072\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
prefoldin subunit 3 (von hippel-lindau binding protein 1) (vhl binding protein-1) (vbp-1) (hibbj46). [source:swissprot;acc:q15765]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5207.39\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5687.2\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09214\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1073\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
prefoldin subunit 2 (hspc231). [source:swissprot;acc:q9uhv9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1074\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
uxt protein (ubiquitously expressed transcript protein) (hspc024). [source:swissprot;acc:q9ubk9]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1075\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidate cytidylyltransferase 1 (ec 2.7.7.41) (cdp-diglyceride synthetase 1) (cdp-diglyceride pyrophosphorylase 1) (cdp- diacylglycerol synthase 1) (cds 1) (ctp:phosphatidate cytidylyltransferase 1) (cdp-dag synthase 1) (cdp-dg synthetase 1). [source:swissprot;acc:q92903]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6441.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7034.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09211\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1076\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 4 (na+/sulfate cotransporter sut-1). [source:swissprot;acc:q9ukg4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6439.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7032.19\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09202\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1077\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 3 (sodium-dependent high-affinity dicarboxylate transporter 2) (na(+)/dicarboxylate cotransporter 3) (nadc-3) (hnadc3). [source:swissprot;acc:q8wwt9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6439.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7032.22\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1078\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 1 (renal sodium/sulfate cotransporter) (na(+)/sulfate cotransporter) (hnasi-1). [source:swissprot;acc:q9bzw2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6439.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7032.19\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1079\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 2 (renal sodium/dicarboxylate cotransporter) (na(+)/dicarboxylate cotransporter 1) (nadc-1). [source:swissprot;acc:q13183]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6439.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7032.22\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1080\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 2. [source:swissprot;acc:o15127]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6439.3\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7031.73\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.092\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1081\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 3. [source:swissprot;acc:o14828]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1082\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 1. [source:swissprot;acc:o15126]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6439.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7031.8\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1083\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exocyst complex component sec15b. [source:swissprot;acc:q9y2d4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6213.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6785.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09198\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1084\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidate cytidylyltransferase 2 (ec 2.7.7.41) (cdp-diglyceride synthetase 2) (cdp-diglyceride pyrophosphorylase 2) (cdp- diacylglycerol synthase 2) (cds 2) (ctp:phosphatidate cytidylyltransferase 2) (cdp-dag synthase 2) (cdp-dg synthetase 2). [source:swissprot;acc:o95674]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6437.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7029.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09192\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1085\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycerol-3-phosphate transporter (g-3-p transporter) (g-3-p permease). [source:swissprot;acc:p57057]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6520.28\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7119.28\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09187\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1086\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proline oxidase, mitochondrial precursor (ec 1.5.3.-) (proline dehydrogenase). [source:swissprot;acc:o43272]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1087\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
junction plakoglobin (desmoplakin iii). [source:swissprot;acc:p14923]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5732.73\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6256.63\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09139\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1088\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tax interaction protein 1. [source:refseq;acc:nm\_014604]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1089\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine--pyruvate aminotransferase (ec 2.6.1.51) (spt) (alanine-- glyoxylate aminotransferase) (ec 2.6.1.44) (agt). [source:swissprot;acc:p21549]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6390.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6973.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0912\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1090\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
interleukin enhancer-binding factor 1 (cellular transcription factor ilf-1). [source:swissprot;acc:q01167]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5651.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6164.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09086\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1091\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyadenylate-binding protein 3 (poly(a)-binding protein 3) (pabp 3) (testis-specific poly(a)-binding protein). [source:swissprot;acc:q9h361]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5791.05\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6316.61\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09075\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1092\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hskin17 protein. [source:refseq;acc:nm\_012311]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1093\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
carnitine o-acetyltransferase (ec 2.3.1.7) (carnitine acetylase) (cat). [source:swissprot;acc:p43155]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1094\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyadenylate-binding protein 4 (poly(a)-binding protein 4) (pabp 4) (inducible poly(a)-binding protein) (ipabp) (activated-platelet protein-1) (app-1). [source:swissprot;acc:q13310]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1095\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyadenylate-binding protein 1 (poly(a)-binding protein 1) (pabp 1). [source:swissprot;acc:p11940]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1096\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin protein. [source:refseq;acc:nm\_032559]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5356.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5842.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09072\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1097\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homolog of yeast maf1. [source:refseq;acc:nm\_032272]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6133.83\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6690.18\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0907\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1098\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor differentially expressed protein 2. [source:refseq;acc:nm\_178865]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1099\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor differentially expressed protein 1 (transmembrane protein sbbi99). [source:swissprot;acc:q13530]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1100\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor differentially expressed 1 protein like. [source:swissprot;acc:q9nrx5]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1101\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
d-3-phosphoglycerate dehydrogenase (ec 1.1.1.95) (3-pgdh). [source:swissprot;acc:o43175]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1102\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phenylalanyl-trna synthetase beta chain (ec 6.1.1.20) (phenylalanine-- trna ligase beta chain) (phers) (hspc173). [source:swissprot;acc:q9nsd9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5462.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5958.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09066\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1103\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ny-ren-62 antigen (fragment). [source:sptrembl;acc:q9y590]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5358.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5843.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09062\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1104\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin-like protein kif2 (kinesin-2) (hk2). [source:swissprot;acc:o00139]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5359.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5844.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09054\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1105\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
synaptotagmin xii (sytxii). [source:swissprot;acc:q8iv01]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5460.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5954.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09049\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1106\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peptide methionine sulfoxide reductase (ec 1.8.4.6) (protein- methionine-s-oxide reductase) (peptide met(o) reductase). [source:swissprot;acc:q9uj68]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5489.99\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5986.63\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09046\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1107\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoserine aminotransferase (ec 2.6.1.52) (psat). [source:swissprot;acc:q9y617]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/